D.C. Diagnosis

D.C. Diagnosis John Wilkerson

STAT Plus: GOP hits resistance on Medicaid cuts, and a brewing plan to lower drug prices

D.C. Diagnosis John Wilkerson

STAT Plus: Bipartisan support for federal research funding, and Dems sharpen arguments against Medicaid work requirements

D.C. Diagnosis John Wilkerson

STAT Plus: Congress returns to a jam-packed agenda — here’s what we’re watching

D.C. Diagnosis John Wilkerson

STAT Plus: Prestigious journal gets U.S. attorney letter, Trump’s HIV cuts slammed

D.C. Diagnosis John Wilkerson

STAT Plus: Research grants as political ammo; Death to dyes?

D.C. Diagnosis John Wilkerson

STAT Plus: RFK Jr. is back to criticizing vaccines, and Trump’s new drug-cost plan

D.C. Diagnosis John Wilkerson

STAT Plus: RFK Jr.’s Senate hearing delayed, living with more measles

D.C. Diagnosis John Wilkerson

STAT Plus: More research funding cuts and potential layoffs, from Columbia to AHRQ

D.C. Diagnosis Sarah Owermohle

STAT Plus: A little-known HHS agency may face big layoffs

D.C. Diagnosis John Wilkerson

STAT Plus: What’s in the GOP’s stopgap government funding bill?

D.C. Diagnosis Sarah Owermohle

STAT Plus: Trump’s FDA navigates layoffs, exits, and a new hire

D.C. Diagnosis STAT Staff and Sarah Owermohle

STAT Plus: RFK Jr. could resurrect a vaccine safety board — what it means

D.C. Diagnosis John Wilkerson

STAT Plus: What to know about MAHA as RFK Jr. nears powerful health care role

D.C. Diagnosis Sarah Owermohle

STAT Plus: A crucial moment for RFK Jr. And for Bill Cassidy

D.C. Diagnosis John Wilkerson

STAT Plus: Takeaways from RFK Jr.’s first day before Congress

D.C. Diagnosis Sarah Owermohle

STAT Plus: Unpacking RFK Jr.’s plans for vaccines

D.C. Diagnosis John Wilkerson

STAT Plus: From FDA to JPM, MAHA is top of mind

D.C. Diagnosis Sarah Owermohle

STAT Plus: The Supreme Court considers another challenge to the ACA

D.C. Diagnosis John Wilkerson

STAT Plus: Trump faces an ACA subsidy conundrum

D.C. Diagnosis Sarah Owermohle

STAT Plus: What does Medicaid look like in a second Trump presidency?

D.C. Diagnosis John Wilkerson

STAT Plus: The health care deal is in jeopardy

D.C. Diagnosis Sarah Owermohle

STAT Plus: PBMs face scrutiny from all sides, and analyzing Marty Makary’s road to the FDA

D.C. Diagnosis John Wilkerson

STAT Plus: How RFK Jr. could impact addiction treatment

D.C. Diagnosis Sarah Owermohle

STAT Plus: Budget negotiations heat up as ACA subsidy extension, BIOSECURE get dropped

D.C. Diagnosis John Wilkerson

What’s ahead for Trump nominees’ confirmations

D.C. Diagnosis Sarah Owermohle

STAT Plus: The Supreme Court cases already shaping Trump’s term

D.C. Diagnosis Sarah Owermohle

STAT Plus: Unpacking Trump’s latest picks for top health roles

D.C. Diagnosis John Wilkerson

STAT Plus: GOP senators, Biden officials ponder RFK Jr. and what Trump may do on health care

D.C. Diagnosis Rachel Cohrs Zhang

D.C. Diagnosis: RFK Jr. targets the F in FDA